Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Chris Dickhoff
Assessing actionable Radiological Features on Serial CT Images in Post-SABR Patients with resected Local Recurrence of Colorectal Lung Metastases.
Keywords Colorectal lung metastases stereotactic ablative radiotherapy local recurrence actionable radiological features salvage resection pulmonary metastases Get full text access Log in, subscribe or purchase for full access. 8. References 1. Cervantes, A. ∙ Adam, R. ∙ Roselló, S. ... Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Ann Oncol. 2023 Jan; 34(1):10-32 2. Mayinger, M. ∙ Kotecha, R. ∙ Sahgal, A. ...
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study
Discussion To the best of our knowledge, the INCREASE study is the first to investigate the safety and efficacy of adding dual immunotherapy, using a PD-1 and a CTLA-4 blocker, to high-dose concurrent CRT in the neoadjuvant setting for locally advanced NSCLC. Our main findings were a pCR and MPR in 50% (15/30) and 63% (19/30) of the ITT population, and in 58% (15/26) and 73% (19/26) of patients who underwent surgery, respectively.
Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
1. Background Pulmonary metastasectomy and stereotactic ablative radiotherapy (SABR; also known as stereotactic body radiotherapy, SBRT) are both guideline-supported treatments for radical-intent local therapy of pulmonary oligo-metastases in selected colorectal cancer (CRC) patients.
Salvage surgery for local recurrences after stereotactic ablative radiotherapy of colorectal pulmonary metastases
4 DISCUSSION This report represents the largest series to date of patients with pulmonary metastases from colorectal cancer undergoing a salvage resection for local recurrence after SABR. Our main findings were that a complete (R0) resection was achieved in all patients, with acceptable morbidity (20%) and no 90-day mortality. In this highly selected cohort, patients had a good oncological outcome, with an estimated median OS of 71 months and PFS of 38 months.
Prognostic value of proliferation, PD-L1 and nuclear size in patients with superior sulcus tumours treated with chemoradiotherapy and surgery
http://orcid.org/0000-0001-6158-7288Hans Blaauwgeers1, Birgit I Lissenberg-Witte2, Chris Dickhoff3, Sylvia Duin4, Erik Thunnissen4 1 Department of Pathology, OLVG LAB BV, Amsterdam, The Netherlands 2 Department of Epidemiology and Data Science, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands 3 Department of Surgery and Cardiothoracic Surgery, Amsterdam UMC - Cancer Center Amsterdam, Amsterdam, The Netherlands 4 Department of Pathology, Location Vrije Universiteit Amsterdam,...
Persistent Postthyroidectomy Hypoparathyroidism in the Netherlands
Original Investigation October 7, 2021 JAMA Otolaryngol Head Neck Surg. Published online October 7, 2021. doi:10.1001/jamaoto.2021.2475 Key Points Question What is the incidence of postoperative, persistent hypoparathyroidism after total or completion thyroidectomy in a university hospital patient population?
Prognostic value of proliferation, PD-L1 and nuclear size in patients with superior sulcus tumours treated with chemoradiotherapy and surgery
Prognostic value of proliferation, PD-L1 and nuclear size in patients with superior sulcus tumours treated with chemoradiotherapy and surgery http://orcid.org/0000-0001-6158-7288Hans Blaauwgeers1, Birgit I Lissenberg-Witte2, Chris Dickhoff3, Sylvia Duin4, Erik Thunnissen4 1Department of Pathology, OLVG LAB BV, Amsterdam, The Netherlands 2Department of Epidemiology and Data Science, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands 3Department of Surgery and Cardiothoracic...
Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?
Highlights • Salvage surgery for local recurrence should be considered in selected patients. • Salvage pneumonectomy is associated with minimal morbidity and mortality. • DFS and OS are better in patients in whom an R0 resection was performed. • Recurrence and subsequent surgery more than 12 months after CRT seem to do better.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Chris
Contact Chris, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack